These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1153488)

  • 1. [Injection molding technic for the production of oral retard preparations. 2. Structure of the matrix].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Apr; 30(4):229-33. PubMed ID: 1153488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Injection-molding technic for the production of oral delayed action preparations. 1. Injection molding].
    Hüttenrauch R
    Pharmazie; 1974 May; 29(5):297-302. PubMed ID: 4603635
    [No Abstract]   [Full Text] [Related]  

  • 3. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Types of controlled-release dosage forms].
    Huang SY
    Yao Xue Xue Bao; 1986 Feb; 21(2):152-7. PubMed ID: 3529817
    [No Abstract]   [Full Text] [Related]  

  • 5. [Injection molding of oral retard preparations. Part 6. Variations in outer surface geometry].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1976; 31(10):724-8. PubMed ID: 1019196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Injection molding of preoral sustained-release preparations. 5. Development of a solid foam body].
    Schmeiss U; Hüttenrauch R
    Pharmazie; 1976 Aug; 31(8):559-62. PubMed ID: 996077
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid-based vehicle for oral drug delivery.
    Stuchlík M; Zák S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2001 Dec; 145(2):17-26. PubMed ID: 12426768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revolution in dosage forms.
    Pepper GA
    Nurse Pract; 1986 May; 11(5):76, 81-2, 84. PubMed ID: 3703398
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 11. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
    Jannin V; Pochard E; Chambin O
    Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formulation and characterization of oral galenic forms in a sustained-release type matrix].
    Buri P
    Boll Chim Farm; 1984 Oct; 123(10):453-64. PubMed ID: 6529489
    [No Abstract]   [Full Text] [Related]  

  • 14. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physical ageing of amorphous polymeric excipients III. The possible consequences of ageing].
    Zelkó R; Kiss D
    Acta Pharm Hung; 2006; 76(2):105-13. PubMed ID: 17094669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid oral dosage forms.
    Helliwell M; Taylor D
    Prof Nurse; 1993 Feb; 8(5):313-7. PubMed ID: 8451252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A review of pharmaceutics in the 1980's and its prospect].
    Huang SY
    Yao Xue Xue Bao; 1991; 26(3):234-40. PubMed ID: 1957667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Are the so-called "delayed-action" oral drugs reliable?].
    Moës AJ
    Bull Mem Acad R Med Belg; 1988; 143(7-9):389-99. PubMed ID: 3252955
    [No Abstract]   [Full Text] [Related]  

  • 19. A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Donauer N; Löbenberg R
    Int J Pharm; 2007 Dec; 345(1-2):2-8. PubMed ID: 17935916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.